1. Regulation of macrophage phagocytosis

   • D. L. Coleman

   Review Pages: 1 - 5

2. Molecular genetics of exopolysaccharide production by mucoidPseudomonas aeruginosa

   • D. E. Ohman

   Editorials Pages: 6 - 10

3. Antibiotic-induced bacterial cell lysis: A therapeutic dilemma

   • J. L. Shenep

   Editorials Pages: 11 - 12

4. Release of endotoxin from bacteria exposed to ciprofloxacin and its prevention with polymyxin B

   • J. Cohen
   • J. S. McConnell

   Articles Pages: 13 - 17

5. In vitro activity of the aryl-fluoroquinolones A-56619 and A-56620 and evaluation of disk susceptibility tests

   • A. L. Barry
   • R. N. Jones
   • E. H. Gerlach

   Articles Pages: 18 - 22

6. Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection

   • N. X. Chin
   • K. Jules
   • H. C. Neu

   Articles Pages: 23 - 28

7. Factors influencing the activity of the trometamol salt of fosfomycin

   • D. Greenwood
   • A. Jones
   • A. Eley

   Articles Pages: 29 - 34

8. Gangrenous cholecystitis and acute cholangitis associated with anaerobic bacteria in bile

   • C. Marne
   • R. Pallarés
   • A. Sitges-Serra

   Articles Pages: 35 - 39

9. Catheter sepsis due to coagulase-negative staphylococci in patients on total parenteral nutrition

   • S. Capell
   • J. Liñares
   • A. Sitges-Serra

   Notes Pages: 40 - 42

10. Commercial kit for preliminary indentification ofStaphylococcus saprophyticus in urine

    • K. K. Christensen
    • P. Christensen

    Notes Pages: 42 - 44

11. Dot-immunobinding assay with a monoclonal antibody for detection of group B meningococcal antigen

    • P. Coll
    • L. Borche
    • G. Prats

    Notes Pages: 44 - 46

12. Diagnosis ofGardnerella vaginalis infection by an enzyme-linked immunosorbent assay

    • M. A. Bratos
    • A. Orduña
    • A. Rodriguez-Torres

    Notes Pages: 46 - 48

13. Activity of teicoplanin against coagulase-negative staphylococci isolated from patients undergoing continuous peritoneal dialysis

    • W. Brumfitt
    • J. M. T. Hamilton-Miller

    Notes Pages: 48 - 49

14. Clinical isolates ofCryptococcus neoformans from Zaire

    • D. Swinne
    • J. B. Nkurikiyinfura
    • T. L. Muyembe

    Notes Pages: 50 - 51

15. In vitro antimicrobial susceptibility of penicillinase-producingNeisseria gonorrhoeae in Japan

    • A. Tsuji
    • F. Ikeda
    • S. Goto

    Notes Pages: 51 - 52

16. Antibiotic prophylaxis in endoscopic retrograde cholangiopancreatography

    • J. I. Blenkharn
    • J. N. Thompson
    • L. H. Blumgart

    Letters to the Editor Pages: 53 - 53

17. Molecular weight of the major outer membrane protein ofLegionella pneumophila

    • P. Hoffman

    Letters to the Editor Pages: 53 - 54

18. Gardnerella vaginalis in urinary tract infections of renal allograft patients

    • E. von der Lippe
    • T. Midtvedt

    Letters to the Editor Pages: 54 - 54

19. Introduction

    • S. C. Schimpff
    • J. Klastersky

    Current Topic: Serum Bactericidal Assay — Technical Aspects and Clinical Correlations Pages: 55 - 57

20. Measurement of bactericidal activity in body fluids as a clinical research procedure

    • P. Dejace
    • J. Klastersky

    Editorials Pages: 58 - 60

21. Standardization of the serum bactericidal test and its relationship to levels of antimicrobial agents

    • C. W. Stratton

    Editorials Pages: 61 - 66

22. Value of the serum bactericidal test in management of patients with bacterial endocarditis

    • J. W. Mellors
    • D. L. Coleman
    • V. T. Andriole

    Reviews Pages: 67 - 70

23. Serum bactericidal test in volunteers — A review

    • S. C. Schimpff
    • G. L. Drusano
    • H. C. Standiford

    Reviews Pages: 71 - 78

24. Technical aspects and clinical correlations of the serum bactericidal test

    • H. C. Standiford
    • B. A. Tatem

    Reviews Pages: 79 - 87

25. Correlation of predicted serum bactericidal activities and values measured in volunteers

    • G. Drusano
    • H. Standiford
    • S. Schimpff

    Articles Pages: 88 - 92

26. Serum bactericidal titer as a predictor of outcome in endocarditis

    • C. J. Hackbarth
    • H. F. Chambers
    • M. A. Sande

    Articles Pages: 93 - 97

27. Effect of increasing doses of amikacin with or without piperacillin in the serum bactericidal test

    • H. Lagast
    • A. Pascual-Lopez
    • J. Klastersky

    Articles Pages: 98 - 102

28. Serum fungistatic and fungicidal activity in volunteers receiving antifungal agents

    • F. Meunier

    Articles Pages: 103 - 109

29. Serum bactericidal activity of mezlocillin, ceftazidime, mezlocillin/ceftazidime and mezlocillin/amikacin againstKlebsiella pneumoniae andPseudomonas aeruginosa

    • Y. Van Laethem
    • J. Klastersky

    Articles Pages: 110 - 114

30. Comparison of the serum bactericidal activity of ceftriaxone/ piperacillin and ceftriaxone/netilmicin

    • K. Machka
    • M. Röbl
    • I. Braveny

    Articles Pages: 115 - 118

31. Evaluation of novel antipseudomonal drugs using the serum bactericidal activity test

    • I. Braveny
    • K. Machka
    • D. Milatovic

    Articles Pages: 119 - 123

32. Announcements

    Announcement Pages: 124 - 124

33. Iron and Infection

    • J. J. Bullen

    Erratum Pages: 132 - 132